Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
08/08/2022
08/09/2022
08/10/2022
08/11/2022
08/12/2022
Date
25.17
24.71
25.1
25.55
25.32
Last
6259283
5931133
5300468
4361097
3151138
Volume
-2.21%
-1.83%
+1.58%
+1.79%
-0.90%
Change
Estimated financial data (e) CNY USD
Sales 2022
16 839 M
2 497 M
2 497 M
Net income 2022
1 045 M
155 M
155 M
Net cash position 2022
1 581 M
234 M
234 M
P/E ratio 2022
14,2x
Yield 2022
1,55%
Sales 2023
20 100 M
2 980 M
2 980 M
Net income 2023
1 279 M
190 M
190 M
Net cash position 2023
1 873 M
278 M
278 M
P/E ratio 2023
11,7x
Yield 2023
1,91%
Capitalization
15 093 M
2 238 M
2 238 M
EV / Sales 2022
0,80x
EV / Sales 2023
0,66x
Nbr of Employees
32 503
Free-Float
48,9%
Yixintang Pharmaceutical Group Co., Ltd., formerly Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd., is a China-based company principally engaged in the pharmaceutical chain retailing and pharmaceutical wholesaling businesses. The Company’s main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The Company...
Ratings of Yixintang Pharmaceutical Group Co., Ltd.
All news about YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
06/22 Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online MT
04/29 Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter.. CI
04/22 Yixintang Pharmaceutical Group Co., Ltd. Proposes Cash Dividend on A Shares for the Yea.. CI
04/21 Yixintang Pharmaceutical Group Co., Ltd. Approves Profit Distribution CI
04/01 UBS Adjusts Yixintang Pharmaceutical's Price Target to 51 Yuan From 56.50 Yuan, Keeps a.. MT
03/30 Yixintang Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
03/14 Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End.. CI
2021 Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months E.. CI
2021 Yixintang Pharmaceutical Co., Ltd. announced that it has received CNY 250 million in fu.. CI
2021 Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year End.. CI
2021 Yixintang Pharmaceutical Co., Ltd. announced that it expects to receive CNY 250 million.. CI
2021 YIXINTANG PHARMACEUTICAL : Pharma to List Over 2 Million Newly Unlocked Restricted SharesMT
2021 Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter.. CI
2021 Yixintang Pharmaceutical Group Co., Ltd. Approves Cash Dividend A Shares for the Year 2.. CI
2021 YIXINTANG PHARMACEUTICAL : Pharma to List New Shares Issued Under Incentive PlanMT
News in other languages on YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Analyst Recommendations on YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Chart YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends YIXINTANG PHARMACEUTICAL GROUP CO., LTD.
Short Term Mid-Term Long Term Trends Bullish Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
10
Last Close Price
25,32 CNY
Average target price
36,84 CNY
Spread / Average Target
45,5%
Please enable JavaScript in your browser's settings to use dynamic charts.